POST Online Media Lite Edition


New York AG reaches $1.1 billion agreement with big three distributors to treat and prevent opioid use

Christian Fernsby |
New York Attorney General Letitia James announced an agreement with McKesson Corporation, Cardinal Health Inc., and Amerisource Bergen Drug Corporation — three of the nation’s largest drug distributors — that will deliver up to $1.1 billion to New York state to combat the ongoing opioid epidemic.

Article continues below

The $1.1 billion agreement is the largest monetary settlement ever negotiated by Attorney General James.

The agreement resolves claims made by Attorney General James for the three companies’ role in helping to fuel the opioid epidemic and will remove the three distributors from New York’s ongoing opioid trial, currently underway in Suffolk County State Supreme Court.

“For more than two decades, the opioid epidemic has wreaked havoc on countless communities throughout New York and across the rest of the nation, killing hundreds of thousands of our friends and family members and addicting millions more,” said Attorney General James.

“And over the course of these past two decades, McKesson, Cardinal Health, and Amerisource Bergen distributed these opioids without regard to the national crisis they were helping to fuel. But today, we’re holding them accountable and delivering more than $1 billion more into New York communities ravaged by opioids for treatment, recovery, and prevention efforts — bringing the statewide total our office has negotiated in the last month alone to more than $1.6 billion. While no amount of money will ever compensate for the millions of addictions, the hundreds of thousands of deaths, or the countless communities decimated by opioids, this money will be vital in preventing any future devastation.”

As part of today’s agreement, McKesson, Cardinal Health, and Amerisource Bergen will pay New York state a total of up to $1,179,251,066.68, of which more than $1 billion will go towards abatement. Payments will start in just two months and will continue over the course of the next 17 years.

The majority of the $1.1 billion payment will be a guaranteed, base payment, with the remaining funds earmarked as incentive payments to be paid if New York maximally bars, resolves, or releases current and future subdivision litigation.

Put simply, the greater the level of participation from political subdivisions across New York state, the more funds that ultimately will be paid out for abatement to the state and to local communities over the course of the 18 total years.

More specifically, agreement ensures the vast majority of funds will be allocated and tracked at a regional level to communities across the state that have been most hard hit by the opioid epidemic.

Part of payment includes New York’s share of a national pot that will be provided to states that did not hire outside counsel.

Like most other funds announced today, these funds will be used for abatement purposes and will not go toward the state’s general fund. Finally, any national fund created to compensate private practice attorneys for lawyers’ fees will also be used to pay private attorneys used by New York’s political subdivisions, ensuring the more than $1 billion being announced today for opioid abatement will not be allocated to anything else.

What to read next

New York to pay $1 million, invest $2.975 billion in water quality
Refund checks issued to New York retirees decieved by pension advance company
Intesa Sanpaolo fined $235 million by New York regulator